Rumors have already been crossing wires that Pfizer Inc. (NYSE:PFE) might be interested in a takeover of its UK-based rival GlaxoSmithKline plc (ADR) (NYSE:GSK). Deutsche Bank's analyst Gregg Gilbert added fuel to these speculations on Wednesday by placing a dollar value to the acquisition.
Please to comment